Selected research
Industry Research
Blood Preparation Industry Research Report 2026
Market perspective
The global Blood Preparation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Blood Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Blood Preparation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Blood Preparation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Blood Preparation include Pfizer, GlaxoSmithKline, Baxter Healthcare Corp, AstraZeneca, Sanofi Aventis, Leo Pharma, Celgene Corporation and Bristol-Myers Squibb Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Blood Preparation market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blood Preparation Market by Company
Pfizer
GlaxoSmithKline
Baxter Healthcare Corp
AstraZeneca
Sanofi Aventis
Leo Pharma
Celgene Corporation
Bristol-Myers Squibb Company
Blood Preparation Segment by Type
Blood Components
Whole Blood
Blood Derivatives
Blood Preparation Segment by Application
Thrombocytosis
Angina Blood Vessel Complications
Renal Impairment
Pulmonary Embolism
Others
Blood Preparation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Preparation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blood Preparation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blood Preparation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blood Preparation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Components
- Whole Blood
- Blood Derivatives
Applications
- Thrombocytosis
- Angina Blood Vessel Complications
- Renal Impairment
- Pulmonary Embolism
- Others
Companies covered
- Pfizer
- GlaxoSmithKline
- Baxter Healthcare Corp
- AstraZeneca
- Sanofi Aventis
- Leo Pharma
- Celgene Corporation
- Bristol-Myers Squibb Company
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Blood Preparation Market Size (2021-2032)
- 2.2.2 Global Blood Preparation Sales (2021-2032)
- 2.2.3 Global Blood Preparation Market Average Price (2021-2032)
- 2.3 Blood Preparation by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Blood Components
- 2.3.3 Whole Blood
- 2.3.4 Blood Derivatives
- 2.4 Blood Preparation by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Thrombocytosis
- 2.4.3 Angina Blood Vessel Complications
- 2.4.4 Renal Impairment
- 2.4.5 Pulmonary Embolism
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Blood Preparation Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Blood Preparation Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Blood Preparation Revenue of Manufacturers (2021-2026)
- 3.4 Global Blood Preparation Average Price by Manufacturers (2021-2026)
- 3.5 Global Blood Preparation Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Blood Preparation, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Blood Preparation, Product Type & Application
- 3.8 Global Manufacturers of Blood Preparation, Established Date
- 3.9 Global Blood Preparation Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Blood Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Blood Preparation Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 GlaxoSmithKline
- 4.2.1 GlaxoSmithKline Company Information
- 4.2.2 GlaxoSmithKline Business Overview
- 4.2.3 GlaxoSmithKline Blood Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GlaxoSmithKline Blood Preparation Product Portfolio
- 4.2.5 GlaxoSmithKline Recent Developments
- 4.3 Baxter Healthcare Corp
- 4.3.1 Baxter Healthcare Corp Company Information
- 4.3.2 Baxter Healthcare Corp Business Overview
- 4.3.3 Baxter Healthcare Corp Blood Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baxter Healthcare Corp Blood Preparation Product Portfolio
- 4.3.5 Baxter Healthcare Corp Recent Developments
- 4.4 AstraZeneca
- 4.4.1 AstraZeneca Company Information
- 4.4.2 AstraZeneca Business Overview
- 4.4.3 AstraZeneca Blood Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca Blood Preparation Product Portfolio
- 4.4.5 AstraZeneca Recent Developments
- 4.5 Sanofi Aventis
- 4.5.1 Sanofi Aventis Company Information
- 4.5.2 Sanofi Aventis Business Overview
- 4.5.3 Sanofi Aventis Blood Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sanofi Aventis Blood Preparation Product Portfolio
- 4.5.5 Sanofi Aventis Recent Developments
- 4.6 Leo Pharma
- 4.6.1 Leo Pharma Company Information
- 4.6.2 Leo Pharma Business Overview
- 4.6.3 Leo Pharma Blood Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Leo Pharma Blood Preparation Product Portfolio
- 4.6.5 Leo Pharma Recent Developments
- 4.7 Celgene Corporation
- 4.7.1 Celgene Corporation Company Information
- 4.7.2 Celgene Corporation Business Overview
- 4.7.3 Celgene Corporation Blood Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Celgene Corporation Blood Preparation Product Portfolio
- 4.7.5 Celgene Corporation Recent Developments
- 4.8 Bristol-Myers Squibb Company
- 4.8.1 Bristol-Myers Squibb Company Company Information
- 4.8.2 Bristol-Myers Squibb Company Business Overview
- 4.8.3 Bristol-Myers Squibb Company Blood Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bristol-Myers Squibb Company Blood Preparation Product Portfolio
- 4.8.5 Bristol-Myers Squibb Company Recent Developments
5 Global Blood Preparation Market Scenario by Region
- 5.1 Global Blood Preparation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Blood Preparation Sales by Region: 2021-2032
- 5.2.1 Global Blood Preparation Sales by Region: 2021-2026
- 5.2.2 Global Blood Preparation Sales by Region: 2027-2032
- 5.3 Global Blood Preparation Revenue by Region: 2021-2032
- 5.3.1 Global Blood Preparation Revenue by Region: 2021-2026
- 5.3.2 Global Blood Preparation Revenue by Region: 2027-2032
- 5.4 North America Blood Preparation Market Facts & Figures by Country
- 5.4.1 North America Blood Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Blood Preparation Sales by Country (2021-2032)
- 5.4.3 North America Blood Preparation Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Blood Preparation Market Facts & Figures by Country
- 5.5.1 Europe Blood Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Blood Preparation Sales by Country (2021-2032)
- 5.5.3 Europe Blood Preparation Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Blood Preparation Market Facts & Figures by Country
- 5.6.1 Asia Pacific Blood Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Blood Preparation Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Blood Preparation Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Blood Preparation Market Facts & Figures by Country
- 5.7.1 South America Blood Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Blood Preparation Sales by Country (2021-2032)
- 5.7.3 South America Blood Preparation Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Blood Preparation Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Blood Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Blood Preparation Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Blood Preparation Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Blood Preparation Sales by Type (2021-2032)
- 6.1.1 Global Blood Preparation Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Blood Preparation Sales Market Share by Type (2021-2032)
- 6.2 Global Blood Preparation Revenue by Type (2021-2032)
- 6.2.1 Global Blood Preparation Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Blood Preparation Revenue Market Share by Type (2021-2032)
- 6.3 Global Blood Preparation Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Blood Preparation Sales by Application (2021-2032)
- 7.1.1 Global Blood Preparation Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Blood Preparation Sales Market Share by Application (2021-2032)
- 7.2 Global Blood Preparation Revenue by Application (2021-2032)
- 7.2.1 Global Blood Preparation Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Blood Preparation Revenue Market Share by Application (2021-2032)
- 7.3 Global Blood Preparation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Blood Preparation Value Chain Analysis
- 8.1.1 Blood Preparation Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Blood Preparation Production Mode & Process
- 8.2 Blood Preparation Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Blood Preparation Distributors
- 8.2.3 Blood Preparation Customers
9 Global Blood Preparation Analyzing Market Dynamics
- 9.1 Blood Preparation Industry Trends
- 9.2 Blood Preparation Industry Drivers
- 9.3 Blood Preparation Industry Opportunities and Challenges
- 9.4 Blood Preparation Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst